Comparison of traditional risk factors, natural history and angiographic findings between coronary heart disease patients with age <40 and ≥40 years old

Anadolu Kardiyoloji Dergisi

Volumn 7, Issue 2, 2007, Pages 124-127

  Yildirin, Nesligül ^a,c   Arat, Nurcan ^b   Doǧan, Mesut Sait ^a   Sökmen, Yeliz ^b   Özcan, Firat ^b  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Coronary heart disease; Old adults; Young adults

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BIOCHEMISTRY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIET THERAPY; DISEASE COURSE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PUBLIC HEALTH; RISK FACTOR; STABLE ANGINA PECTORIS; TURKEY (REPUBLIC);

ADULT; AGE FACTORS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MEDICAL RECORDS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TURKEY;

EID: 34249981243     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ridker MP, Genest J, Libby P. Risk factors for atherosclerotic disease. In: Braunwald E, Zipes DP, Libby P, editors. Heart Disease: A Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: W.B. Saunders Company; 2001. p. 1010-39.
2. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction. N Engl J Med 1984; 311: 1144-7.
3. Weinberger I, Rotenberg Z, Fuchs J, Sagy A, Friedmann J, Agmon J. Myocardial infarction in young adults under 30 years: risk factors and clinical course. Clin Cardiol 1987; 10: 9-15.
4. Perski A, Olsson G, Landou C, de Faire U, Theorell T, Hamsten A. Minimum heart rate and coronary atherosclerosis: independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992; 123: 609-16.
5. Chouhan L, Hajar HA, Pomposiello JC. Comparison of thrombolytic therapy for acute myocardial infarction in patients aged <35 and >55 years. Am J Cardiol 1993; 71: 157-9.
6. Uhl GS, Farrell PW. Myocardial infarction in young adults: risk factors and natural history. Am Heart J 1983; 105: 548-53.
7. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Predicting coronary heart disease in middle-aged and older persons: the Framingham study. JAMA 1977; 238: 497-9.
8. Stokes J, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham study. Circulation 1987; 75 (Suppl 5): V-85-73.
9. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-97.
10. National Cholesterol Education Program (U.S.). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III): final report. Bethesda, Md: National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health; 2002. NIH publication; no. 02-5215.
11. Malmberg K, Bavenholm P, Hamsten A. Clinical and biochemical factors associated with prognosis after myocardial infarction at a young age. J Am Coll Cardiol 1994; 24: 592-9.
12. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson SW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999; 341: 410-8.
13. Mahley RW, Pepin GM, Bersot TP, Palaoglu KE, Ozer K. Turk Kalp Calismasinda Yeni Sonuclar: Plazma lipidleri ve HDL-K dusuklugunde tedavide oneriler. Turk Kardiyol Dern Ars 2002; 30: 93-103.
14. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10.
15. Tokgozoglu L. Turk eriskinlerde lipid, lipoprotein ve apolipoproteinler. In: Onat A, editor. TEKHARF: Oniki Yillik Izleme Gore Turk Eriskinlerde Kalp Sagligi. Istanbul: Mas Matbaacilik A.S; 2003. p. 34-44.
16. Klein LW, Agarwal JB, Herlich MB, Leary TM, Helfant RH. Prognosis of symptomatic coronary artery disease in young adults aged 40 years or less. Am J Cardiol 1987; 60: 1269-72.
17. Nitter Hauge S, Erikssen J, Thaulow E, Vatne K. Angiographic and risk factor characteristics of subjects with early-onset ischaemic heart disease. Br Heart J 1981; 46: 325-30.
18. Wolfe MW, Vacek JL. Myocardial infarction in the young: angiographic features and risk factor analysis of patients with myocardial infarction at or before the age of 35 years. Chest 1988; 94: 926-30.
19. Dollar AL, Kragel AH, Fernicola DJ, Waclawiw MA, Roberts WC. Composition of atherosclerotic plaques in coronary arteries in women less than 40 years of age with fatal coronary artery disease and implications for plaque reversibility. Am J Cardiol 1991; 67: 1223-7.
20. Ambrose JA, Winters SL, Stern A, Haft JI, Goldstein J, Rentrop KP, et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-16.
21. Zimmerman FH, Cameron A, Fisher LD. Myocardial infarction in young adults. Angiographic characterization, risk factors and prognosis (Coronary artery surgery registry). J Am Coll Cardiol 1995; 26: 654-61.
22. Herlitz J, Karlson BW, Bang A, Sjolin M. Survival, mode of death, reinfarction and use of medication during a period of 5 years after acute myocardial infarction in different age groups. Cardiology 1996; 87: 529-36.
23. Marcus FI, Friday K, McCans J, Moon T, Hahn E, Cobb L, et al. Age-related prognosis after acute myocardial infarction (The multi-center diltiazem postinfarction trial). Am J Cardiol 1990; 65: 559-66.